The severity of sleep-disordered breathing and nocturnal hypoxemia independently predicts both glycosylated hemoglobin (HbA1c) levels and type 2 diabetes mellitus (T2DM), according to a new study.
"Because people with obstructive sleep apnea syndrome (OSAS) are often overweight or obese, it has been difficult to interpret earlier studies of the relationship between sleep-disordered breathing and metabolic disorders," said Brian Kent, MBBCh, research fellow at St. Vincent’s University Hospital in Dublin. "We found that obstructive sleep apnea syndrome severity and low nocturnal oxygen levels were significant independent predictors of prevalent T2DM and HbA1c levels, even after adjustment for a number of confounding variables, including obesity."
The study involved 7,886 prospectively assessed subjects from 22 sleep laboratories in 16 European countries. All subjects completed overnight sleep studies.
After adjustment for comorbidities and demographic and anthropometric variables, moderate and severe OSAS were each significant (P =.003) predictors of having a diagnosis of T2DM. Apnea/hypopnea index, oxyhemoglobin desaturation index, and mean oxygen saturation (SpO2) were significant (P <.0001) predictors of HbA1c levels.
"A diagnosis of T2DM is associated with a significantly increased risk of cardiovascular morbidity and death, and elevated HbA1c levels predict cardiovascular mortality in non-diabetic subjects," said Kent. "OSAS has also been shown to be associated with adverse cardio-metabolic outcomes, although whether OSAS independently predicts these outcomes is not clear."
"Our study shows that OSAS is independently associated with metabolic disturbances," said Kent. "This is important because individuals with T2DM or elevated HbA1c levels are more likely to die of cardiovascular disease."
The research was presented at the [removed]ATS 2012 International Conference[/removed] in San Francisco.